SomaLogic (SLGCW) 10-Q2022 Q2 Quarterly report

Filed: 15 Aug 22, 4:55pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: broader, chain, constraint, consumption, COVID, creation, deep, expertise, installation, installed, labor, macroeconomic, miniaturization, nano, Palamedrix, prepaid, pressure, qualification, ramp, recession, redefine, salesforce, site, slight, SSP, tech

Removed: commitment

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated SLGCW transcripts

SLGCW similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SomaLogic, Inc. (the "Company") on Form 10-Q for the quarter ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Shaun Blakeman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.


		SomaLogic, Inc.

Date:	August 15, 2022		/s/ Shaun Blakeman
		Name:	Shaun Blakeman
		Title:	Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.